3-6-16 & 17, Street No. 19, Opp.
Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029
TEST REPORT
Name : [Link] Registered on:05-Jan -2025 10:00
Age/Gender : 19 Years / Male Collected on :05-Jan -2025 10:25
Registration ID : 240200018976 Released on :29-Feb-2025 12:54
Ref. By : Dr. CHANDRA PRIYANKA Printed on :29-Feb-2025 01:00
Sample Type : Jaundice Regn Centre : Kukatpally - 20
MEASURE BILIRUBIN LEVELS
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
Anti HBc Antibodies : Negative [ 0 ] PEIU/mL NA
Method: Enzyme Linked Fluorescent Assay (ELFA)
Interpretation:
Negative <5 PEIU/mL No detectable Anti-HBc IgM antibodies in the specimen.
Equivocal >/= 5 - < 10 PEIU/mL Sample shows low levels of IgM antibodies. Repeat the test with a
second sample after 1-2 months, if clinically indicated.
Positive >/= 10 PEIU/mL Presence of detectable Anti-HBc IgM antibodies in the specimen.
PEIU: Paul Ehrlich International Units
• This assay detects Anti-Hepatitis B Virus core antigen IgM (anti-HBc IgM) in human serum.
• Result should be considered in conjunction with patient symptoms and other laboratory findings especially with test
results of other HBV serologic markers. (HBsAg, Anti HBc Total, HBeAg , Anti HBe Ab and Anti HBs Ab).
DR. C VISHALA SARMA
MD MICROBIOLOGY
MC-2657 Registration No: TSMC/FMR/48439
Page 1 of 5
3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029
TEST REPORT
Name : [Link] Registered on:05-Jan -2025 10:00
Age/Gender : 19 Years / Male Collected on :05-Jan -2025 10:25
Registration ID : 240200018976 Released on :29-Feb-2025 12:54
Ref. By : Dr. CHANDRA PRIYANKA Printed on :29-Feb-2025 01:00
Sample Type : Jaundice Regn Centre : Kukatpally - 20
LIVE FUNCTION TEST - LFT
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
Hepatitis B Surface Antigen - Automated : Nonreactive [ 0.16 ] S/CO NA
Method: Chemiluminescent Microparticle Immuno Assay
(CMIA)
Interpretation :
Nonreactive <1.0 S/CO Specimen is negative for HBsAg or Hepatitis B virus surface antigens are at an
undetectable level.
Reactive >/= 1.0 S/CO Specimen is positive for Hepatitis B surface antigen.
• This test is for the qualitative detection of Hepatitis B surface Antigen (HBsAg) in human serum.
• This assay is useful to monitor and refine treatment of patients with chronic hepatis B virus infection.
• This test is a highly sensitive screening assay; it should not be used as a sole criterion for confirmation of Hepatitis B
infection. Its result should be confirmed by other supplementory tests. Test results should be interpreted in conjunction
with patient history and other HBV serologic markers (eg, anti-HBs Ab, anti-HBc Total and anti-HBc IgM, HBeAg &
Anti HBe Ab)
• Individuals, who recently received Hepatitis B vaccination may have transient positive HBsAg test results.
• Anomalous results may be observed in patients who have routine exposure to animals or to animal serum products
who received preparations of mouse monoclonal antibodies for therapy.
DR. SYED HAROON HUSSAIN
MD MICROBIOLOGY
MC-2657 Registration No: 48289
Page 2 of 5
3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029
TEST REPORT
Name : [Link] Registered on:05-Jan -2025 10:00
Age/Gender : 19 Years / Male Collected on :05-Jan -2025 10:25
Registration ID : 240200018976 Released on :29-Feb-2025 12:54
Ref. By : Dr. CHANDRA PRIYANKA Printed on :29-Feb-2025 01:00
Sample Type : Jaundice Regn Centre : Kukatpally - 20
MRIS ANTIBODY – BLOOD TEST
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
Hepatitis C Antibody : Nonreactive [ 0.11 ] S/CO NA
Method: Chemiluminescent Microparticle Immuno Assay
(CMIA)
Interpretation :
Non Reactive <1.0 S/CO Specimen is negative for HCV antibodies or antibodies are at an
undetectable level.
Reactive >/=1.0 S/CO Specimen is positive for HCV antibodies.
Results are reported as S/CO units (ratio of Sample Relative Light Units to the Cut off Relative Light Units)
• HCV is the most common cause of post transfusion hepatitis. HCV antibodies usually appear in the late convalescent
stage >6 months after onset of infection. This assay is the screening test for resolved or chronic HCV.
• This test is for the qualitative detection of antibody to Hepatitis C Virus in human serum.
• This test is only a screening assay; it should always be used in conjuction with clinical history and exposure risk for
HCV infection.
• This test should not be used as the sole criterion for the confirmation of HCV infection and it is recommended to test
further for HCV RNA detection and quantification by PCR.
• A non-reactive screening result does not exclude the possibility of exposure to or infection with HCV.
DR. SYED HAROON HUSSAIN
MD MICROBIOLOGY
MC-2657 Registration No: 48289
Page 3 of 5
H No. 2-137/10, Plot No.42, NH65, Opposite R.S. Brothers, Gangaram, Chanda Nagar, Hyderabad - 500050, Telangana
TEST REPORT
Name : [Link] Registered on:05-Jan -2025 10:00
Age/Gender : 19 Years / Male Collected on :05-Jan -2025 10:25
Registration ID : 240200018976 Released on :29-Feb-2025 12:54
Ref. By : Dr. CHANDRA PRIYANKA Printed on :29-Feb-2025 01:00
Sample Type : Ac c i den t Regn Centre : Kukatpally - 20
PHYSICAL FULL BODY X RAYS
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
Prothrombin Time : 13.6 Seconds 12.8-15.6
Method: Electromechanical Clot Detection
MNPT : 14.3 Seconds NA
INR : 0.94 Therapeutic Range (2.0 - 4.0)
Method: Electromechanical Clot Detection
Interpretation / Comments :
• PT assesses the coagulation activity of extrinsic and common coagulation pathways .
• PT is prolonged in liver disease, coagulation disorders involving extrinsic coagulation mechanism and common
pathway.
• Marked elevation of INR is seen in patients receiving Vitamin-K antagonist.
DR. D VAISHNAVI
MD PATHOLOGY
MC-5678
Registration No: APMC/FMR/78761
Page 4 of 5
3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029
TEST REPORT
Name : [Link] Registered on:05-Jan -2025 10:00
Age/Gender : 19 Years / Male Collected on :05-Jan -2025 10:25
Registration ID : 240200018976 Released on :29-Feb-2025 12:54
Ref. By : Dr. CHANDRA PRIYANKA Printed on :29-Feb-2025 01:00
Sample Type : Accident Regn Centre : Kukatpally - 20
CT SCANS ANTIBODIES
TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL
HAV IgM Antibodies : Reactive [ 11.64 ] S/CO NA
Method: Chemiluminescent Microparticle Immuno Assay
(CMIA)
Interpretation:
Nonreactive <0.80 S/CO No detectable HAV IgM antibodies in the specimen.
Grey zone 0.80-1.20 S/CO May be due to low levels of antibodies in the sample.
Repeat the test with fresh sample after 1 week, if clinically indicated.
Reactive >1.20 S/CO Presence of detectable HAV IgM antibodies in the specimen.
(S/CO: Sample value/Cut off value)
• Hepatitis A Virus is a self limiting disease transmitted by feco-oral route.
• This assay is used for the qualitative detection of Hepatitis A Virus IgM antibody in human serum.
• HAV IgM antibodies are detectable by the time symptoms appear, usually 15-45 days after exposure. They fall to
undetectable levels by 6 months after HAV infection.
• False reactive test results may be due to presence of cross-reactive antibodies from other viral infection or other
underlying illnesses.
• The result should be correlated with patient symptoms and with the results of other laboratory findings.
• This test should not be used as the sole criterion for the confirmation of HAV infection.
DR. SYED HAROON HUSSAIN
MD MICROBIOLOGY
Registration No: 48289
End of Report
Page 5 of 5
